166 related articles for article (PubMed ID: 31324042)
1. The 3
Pisaneschi F; Lin YH; Leonard PG; Satani N; Yan VC; Hammoudi N; Raghavan S; Link TM; K Georgiou D; Czako B; Muller FL
Molecules; 2019 Jul; 24(13):. PubMed ID: 31324042
[TBL] [Abstract][Full Text] [Related]
2. SF2312 is a natural phosphonate inhibitor of enolase.
Leonard PG; Satani N; Maxwell D; Lin YH; Hammoudi N; Peng Z; Pisaneschi F; Link TM; Lee GR; Sun D; Prasad BAB; Di Francesco ME; Czako B; Asara JM; Wang YA; Bornmann W; DePinho RA; Muller FL
Nat Chem Biol; 2016 Dec; 12(12):1053-1058. PubMed ID: 27723749
[TBL] [Abstract][Full Text] [Related]
3. Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate.
Krucinska J; Lombardo MN; Erlandsen H; Hazeen A; Duay SS; Pattis JG; Robinson VL; May ER; Wright DL
Sci Rep; 2019 Nov; 9(1):17106. PubMed ID: 31745118
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking of alpha-enolase to elucidate the promising candidates against Streptococcus pneumoniae infection.
Hassan M; Baig AA; Attique SA; Abbas S; Khan F; Zahid S; Ain QU; Usman M; Simbak NB; Kamal MA; Yusof HA
Daru; 2021 Jun; 29(1):73-84. PubMed ID: 33537864
[TBL] [Abstract][Full Text] [Related]
5. Structural and Functional Studies of Bacterial Enolase, a Potential Target against Gram-Negative Pathogens.
Krucinska J; Falcone E; Erlandsen H; Hazeen A; Lombardo MN; Estrada A; Robinson VL; Anderson AC; Wright DL
Biochemistry; 2019 Mar; 58(9):1188-1197. PubMed ID: 30714720
[TBL] [Abstract][Full Text] [Related]
6. Enolase Inhibitors as Early Lead Therapeutics against
Roster CP; LaVigne D; Milanes JE; Knight E; Anderson HD; Pizarro S; Harding EM; Morris MT; Yan VC; Pham CD; Muller F; Kwain S; Rees KC; Dominy B; Whitehead DC; Uddin MN; Millward SW; Morris JC
Pathogens; 2023 Oct; 12(11):. PubMed ID: 38003754
[TBL] [Abstract][Full Text] [Related]
7. Enantiomerically pure phosphonated carbocyclic 2'-oxa-3'-azanucleosides: synthesis and biological evaluation.
Romeo R; Carnovale C; Giofrè SV; Monciino G; Chiacchio MA; Sanfilippo C; Macchi B
Molecules; 2014 Sep; 19(9):14406-16. PubMed ID: 25221866
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of enolase: the crystal structures of enolase-Ca2(+)- 2-phosphoglycerate and enolase-Zn2(+)-phosphoglycolate complexes at 2.2-A resolution.
Lebioda L; Stec B; Brewer JM; Tykarska E
Biochemistry; 1991 Mar; 30(11):2823-7. PubMed ID: 2007121
[TBL] [Abstract][Full Text] [Related]
9. Fluoride inhibition of enolase: crystal structure and thermodynamics.
Qin J; Chai G; Brewer JM; Lovelace LL; Lebioda L
Biochemistry; 2006 Jan; 45(3):793-800. PubMed ID: 16411755
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of Trypanosoma brucei enolase: visualisation of the inhibitory metal binding site III and potential as target for selective, irreversible inhibition.
da Silva Giotto MT; Hannaert V; Vertommen D; de A S Navarro MV; Rider MH; Michels PA; Garratt RC; Rigden DJ
J Mol Biol; 2003 Aug; 331(3):653-65. PubMed ID: 12899835
[TBL] [Abstract][Full Text] [Related]
11. Functional and structural changes due to a serine to alanine mutation in the active-site flap of enolase.
Poyner RR; Larsen TM; Wong SW; Reed GH
Arch Biochem Biophys; 2002 May; 401(2):155-63. PubMed ID: 12054465
[TBL] [Abstract][Full Text] [Related]
12. The Synthesis and Absolute Configuration of Enantiomeric Pure (R)- and (S)-3-(piperidin-3-yl)-1H-Indole Derivatives.
Król M; Ślifirski G; Kleps J; Podsadni P; Materek I; Kozioł AE; Herold F
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613958
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition studies of coumarin derivatives on Bos taurus enolase and elucidating their interaction by molecular docking, molecular dynamics simulations and MMGB(PB)SA binding energy calculation.
Sariyer E; Kocer S; Danis O; Turgut-Balik D
Bioorg Chem; 2021 May; 110():104796. PubMed ID: 33799179
[TBL] [Abstract][Full Text] [Related]
14. Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration, and PDE4 inhibitory activity of cis-tetra- and cis-hexahydrophthalazinones.
Van der Mey M; Boss H; Couwenberg D; Hatzelmann A; Sterk GJ; Goubitz K; Schenk H; Timmerman H
J Med Chem; 2002 Jun; 45(12):2526-33. PubMed ID: 12036361
[TBL] [Abstract][Full Text] [Related]
15. Cyclic ketone inhibitors of the cysteine protease cathepsin K.
Marquis RW; Ru Y; Zeng J; Trout RE; LoCastro SM; Gribble AD; Witherington J; Fenwick AE; Garnier B; Tomaszek T; Tew D; Hemling ME; Quinn CJ; Smith WW; Zhao B; McQueney MS; Janson CA; D'Alessio K; Veber DF
J Med Chem; 2001 Mar; 44(5):725-36. PubMed ID: 11262083
[TBL] [Abstract][Full Text] [Related]
16. ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase.
Satani N; Lin YH; Hammoudi N; Raghavan S; Georgiou DK; Muller FL
PLoS One; 2016; 11(12):e0168739. PubMed ID: 28030597
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dog and human gastric lipases by enantiomeric phosphonate inhibitors: a structure-activity study.
Miled N; Roussel A; Bussetta C; Berti-Dupuis L; Rivière M; Buono G; Verger R; Cambillau C; Canaan S
Biochemistry; 2003 Oct; 42(40):11587-93. PubMed ID: 14529268
[TBL] [Abstract][Full Text] [Related]
18. Phosphonate-containing inhibitors of tyrosine-specific protein kinases.
Burke TR; Li ZH; Bolen JB; Marquez VE
J Med Chem; 1991 May; 34(5):1577-81. PubMed ID: 2033582
[TBL] [Abstract][Full Text] [Related]
19. Preparation and configuration of racemic and optically active analgesic cycloaminoalkylnaphthalenes.
Ghislandi V; Collina S; Azzolina O; Barbieri A; Lanza E; Tadini C
Chirality; 1999; 11(1):21-8. PubMed ID: 9914649
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one.
Coutrot P; Claudel S; Didierjean C; Grison C
Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
